Commentary: how to report instrumental variable analyses (suggestions welcome)

Affiliations

Comment

Sonja A Swanson et al. Epidemiology. 2013 May.

. 2013 May;24(3):370-4.

doi: 10.1097/EDE.0b013e31828d0590.

¹ Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. sswanson@hsph.harvard.edu

No abstract available

Comment in

Reporting instrumental variable analyses.
Boef AG, Dekkers OM, le Cessie S, Vandenbroucke JP. Boef AG, et al. Epidemiology. 2013 Nov;24(6):937-8. doi: 10.1097/01.ede.0000434433.14388.a1. Epidemiology. 2013. PMID: 24076999 No abstract available.

COX-2 selective nonsteroidal anti-inflammatory drugs and risk of gastrointestinal tract complications and myocardial infarction: an instrumental variable analysis.
Davies NM, Smith GD, Windmeijer F, Martin RM. Davies NM, et al. Epidemiology. 2013 May;24(3):352-62. doi: 10.1097/EDE.0b013e318289e024. Epidemiology. 2013. PMID: 23532054 Clinical Trial.
Issues in the reporting and conduct of instrumental variable studies: a systematic review.
Davies NM, Smith GD, Windmeijer F, Martin RM. Davies NM, et al. Epidemiology. 2013 May;24(3):363-9. doi: 10.1097/EDE.0b013e31828abafb. Epidemiology. 2013. PMID: 23532055